Baclofen is a GABA-B receptor agonist that acts as a muscle relaxant and has demonstrated potential efficacy in reducing the frequency and intensity of cluster headaches by modulating neurotransmitter release and neural excitability. Its mechanism involves suppressing excessive neuronal firing and potentially interrupting the trigeminal-autonomic pathway activation associated with cluster headache pathogenesis, thereby providing prophylactic benefits for some patients.